Dr. Martin Michaelis is presently working as Professor and Chairperson of Cell Biology, Centre for Molecular Processing and School of Biosciences at University of Kent, UK. He completed his PhD in pharmaceutics in Frankfurt am Main, Germany, working on drug carrier systems including nanoparticles and liposomes. Then, he took a post as postdoc at the Institute for Medical Virology, Clinics of the Goethe-University, Frankfurt/Main, Germany, and started to work on the identification and investigation of anti-cancer and antiviral drugs. He joined the charity “Hilfe für krebskranke Kinder Frankfurt e.V.”, Frankfurt am Main, finally resulting in a joined affiliation at the private research institute of the charity’s trust and carried his career as deputy head of the Department of “Paediatric Tumour and Virus Research”, and “Experimental Virology“, Institute for Medical Virology, Clinics of the Goethe-University, Frankfurt am Main, Germany and then moved to kent University.
Dr. Martin's reserach includes the investigation of a broad range of drugs in cell biology models from the fields of oncology, virology, immunology, and angiogenesis with an interest in colloidal drug delivery systems. He also has a focus on acquired drug resistance in cancer.
